Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2012 /
Influence of cachexia on chemotherapy toxicity

4th - 7th Nov 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.11.12
Views: 3325

Dr Michael Sawyer – University of Alberta, Canada

Dr Michael Sawyer explains that chemotherapy toxicities are related to patient lean body mass and suggests that this may explain the discrepancies that have traditionally been observed in the adverse effects experienced by male and female patients undergoing chemotherapy.


Dr Sawyer’s study also concluded that gastrointestinal and lung cancer patients with a low lean body mass had a lower survival rate, and experienced higher levels of toxicities. 

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation